| Literature DB >> 28708874 |
Maayan Bonjack-Shterengartz1, David Avnir1.
Abstract
The majority of proteins form oligomers which have rotational symmetry. Literature has suggested many functional advantages that the symmetric packing offers. Yet, despite these advantages, the vast majority of protein oligomers are only nearly symmetric. A key question in the field of proteins structure is therefore, if symmetry is so advantageous, why do oligomers settle for aggregates that do not maximize that structural property? The answer to that question is apparently multi-parametric, and involves distortions at the interaction zones of the monomer units of the oligomer in order to minimize the free energy, the dynamics of the protein, the effects of surroundings parameters, and the mechanism of oligomerization. The study of this problem is in its infancy: Only the first parameter has been explored so far. Here we focus on the last parameter-the mechanism of formation. To test this effect we have selected to focus on the domain swapping mechanism of oligomerization, by which oligomers form in a mechanism that swaps identical portions of monomeric units, resulting in an interwoven oligomer. We are using continuous symmetry measures to analyze in detail the oligomer formed by this mechanism, and found, that without exception, in all analyzed cases, perfect symmetry is given away, and we are able to identify that the main burden of distortion lies in the hinge regions that connect the swapped portions. We show that the continuous symmetry analysis method clearly identifies the hinge region of swapped domain proteins-considered to be a non-trivial task. We corroborate our conclusion about the central role of the hinge region in affecting the symmetry of the oligomers, by a special probability analysis developed particularly for that purpose.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28708874 PMCID: PMC5510828 DOI: 10.1371/journal.pone.0180030
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The domain swapping mechanism, demonstrated on the formation of a dimeric oligomer.
(a) Two monomers with their folded potential hinge regions. (b) The monomers with their open hinge regions. (c) The dimerization, leading to the domain-swapped oligomer.
Fig 2The running ruler method demonstrated on the engineered N-terminal domain of CD2 protein (PDB code: 1A64), starting from the N-terminal; running ruler size (red): seven amino-acids (h = 7).
(a) The first segment, 1st-7th amino acids segments-pairs. (b) The second segment, 2nd-8th amino acids segments-pairs. (c) The third segment, 3rd -9th amino acids segments-pairs.
Fig 3Running ruler symmetry analysis applied on RNase A N-terminal swapped dimer (PDB code: 1A2W).
(a) Cartoon representation of the protein. Each subunit is indicated by a different color (blue and green), and the originally proposed hinge region is colored red. (b) CSM spectrum of the protein, the ruler size is as the length of the hinge region (8 amino acids). The black arrow indicates the hinge region. (c) CSM spectrum of the protein with a ruler size of 10 amino acids. The black arrow indicates the hinge region. For data source see ref. [38].
Hinge region location.
| PDB ID | Hinge region from the symmetry analysis | Literature hinge region[ | Shift between the methods |
|---|---|---|---|
| 1WWA | 295–297 | 297–299 | 2 |
| 2SPC | 70–73 | 72–75 | 2 |
| 1LMK | 122–126 | 123–127 | 1 |
| 1JS0 | 111–114 | 112–115 | 1 |
| 1HUL | 81–88 | 82–89 | 1 |
| 1CDC | 43–49 | 44–50 | 1 |
| 1OBP | 121–124 | 121–124 | 0 |
| 1H8X | 17–24 | 16–23 | -1 |
| 1FYR | 122–124 | 121–123 | -1 |
| 1A2W | 16–23 | 15–22 | -1 |
| 1AOJ | 36–41 | 34–39 | -2 |
| 1BSR | 17–24 | 15–22 | -2 |
| 1BLB | 81–89 | 79–87 | -2 |
| 1HT9 | 41–50 | 38–47 | -3 |
| 1BH5 | 24–36 | 20–32 | -4 |
Fig 4The proteins structures analyzed in Fig 5.
Each subunit is indicated by a different color, and the originally proposed hinge region is colored red. (a) N-terminal domain of CD2 (PDB code: 1CDC), (b) Diabody (PDB code: 1LMK), (c) Engineered N-terminal domain of CD2 (PDB code: 1A64), (d) Interleukin-5 (IL-5, PDB code: 1HUL), (e) TrkA-d4 dimer (PDB code: 1WWA). For data sources see ref.'s [39–43].
Fig 6Additional running ruler symmetry analyses (see also S2 Fig); the neighborhood of the hinge region is shown.
Black arrows—the hinge region. (a) Bovine seminal ribonuclease (PDB code: 1BSR), (b) β-crystallin (PDB code: 1BLB), (c) Human pancreatic ribonuclease chimera (PDB code: 1H8X), (d) RNase A N-terminal timer (PDB code: 1JS0), (e) Human glyoxalase I dimer (PDB code: 1BH5), (f) α-spectrin (PDB code: 2SPC), (g) Amyloid-like Cystatin C (PDB code: 1TIJ), (h) SH3 domain of Eps8 (PDB code: 1AOJ), (i) Circadian Clock Protein KaiA (PDB code: 1R8J), (j) Cyanovirin-N (PDB code: 1L5B), (k) Triggering receptor expressed on myeloid cells 1 (TREM-1) (PDB code: 1Q8M), (l) Cystatin A (PDB code: 1N9J), (m) Grb2-SH2 domain dimer (PDB code: 1FYR), (n) Odorant binding protein dimer (PDB code: 1OBP), (o) Cell division protein FtsZ (PDB code: 1W5F), (p) NrdH-redoxin (PDB code: 1R7H). See Table 1 for more information. For data sources see ref.'s [44–59].
Fig 5Running ruler symmetry analysis applied on proteins involved in 3D domain swapping.
The black arrow indicates the hinge region; other colored arrows are explained in the text. (a) N-terminal domain of CD2, hinge region: 44–50, (b) Diabody, hinge region: 123–127, (c) Engineered N-terminal domain of CD2, hinge region: 44–50, (d) Interleukin-5 (IL-5), hinge region: 82–89, (e) TrkA-d4 dimer, hinge region: black– 297–299, red– 295–299. See Fig 4 for their PDB codes and cartoon representation and Table 1 for more information.
Fig 7Focus on the origin of the symmetry distortion: each subunit is indicated by different color.
(a) N-terminal domain of CD2 (PDB code: 1A64) from two different points of view. The amino-acids segments 21–28 and 81–88 are indicated by sticks representation. The interaction between those segments causes the symmetry distortion. These over-crowded regions are surrounded by red circles. (b) Interleukin-5 (PDB code: 1HUL). The regions which are indicated by colored arrows in Fig 5D are colored here respectively. The marked interaction area is seen from two different points of view. For data sources see ref.'s [41,42].
Probability analysis of symmetry distortion at the hinge range.
| PDB ID | Polypeptide chain length | Hinge region | Most distorted amino-acids | Quantity of most distorted amino-acids in hinge region | Probability of the observation |
|---|---|---|---|---|---|
| 1BSR | 124 | 17–24 | 6 / 8 | 5*10−3% | |
| 1A2W | 124 | 16–23 | 85, | 5 / 8 | 1*10−3% |
| 1BLB | 174 | 81–89 | 5 / 9 | 1*10−3% | |
| 1L5X | 270 | 245–249 | 3 / 5 | 3*10−3% | |
| 1QB3 | 109 | 89–95 | 4 / 7 | 0.02% | |
| 1CQZ | 479 | 223–238 | 94, | 5 / 16 | 0.1% |
| 2C5J | 82 | 63–67 | 3 / 5 | 0.1% | |
| 1R8J | 264 | 163–171 | 3 / 9 | 0.2% | |
| 1EN7 | 157 | 62–71 | 4 / 10 | 0.2% | |
| 2QYP | 78 | 21–23 | 2 / 3 | 0.3% | |
| 2HKN | 72 | 37–39 | 2 / 3 | 0.3% | |
| 1JS0 | 124 | 111–114 | 2 / 4 | 0.5% | |
| 2SPC | 107 | 70–73 | 1, 3, | 2 / 4 | 0.6% |
| 1TIJ | 112 | 57–60 | 9, 106, | 2 / 4 | 0.6% |
| 1CDC | 96 | 43–49 | 3 / 7 | 0.8% | |
| 1AOJ | 60 | 36–41 | 3 / 6 | 1% | |
| 2CN4 | 173 | 47–52 | 39, | 2 / 6 | 1% |
| 1WWA | 101 | 295–299 | 2 / 5 | 2% | |
| 2NZ7 | 93 | 91–95 | 39, 101, | 2 / 5 | 2% |
| 1WKQ | 155 | 117–123 | 60, 61, 76, | 2 / 7 | 3% |
| 1L5B | 101 | 48–53 | 2 / 6 | 4% | |
| 1SCE | 102 | 86–91 | 60, | 2 / 6 | 4% |
| 1E7D | 157 | 87–101 | 68, 74, | 4 / 15 | 4% |
| 1Q8M | 121 | 21–23 | 1 / 3 | 7% | |
| 1A64 | 94 | 42–48 | 2 / 7 | 8% | |
| 1G6U | 48 | 32–33 | 1 / 2 | 8% | |
| 1N9J | 98 | 46–49 | 2, | 1 / 3 | 9% |
| 1FYR | 95 | 122–124 | / 3 | 9% | |
| 1OBP | 155 | 121–124 | 96, 157, 153, | 1 / 4 | 10% |
| 1LMK | 239 | 122–126 | 16, | 1 / 5 | 10% |
| 1W5F | 316 | 215–220 | 288, 284, 300, 306, 308, | 1 / 6 | 11% |
| 1R7H | 74 | 49–51 | 40, 37, | 1 / 3 | 12% |
| 5CRO | 61 | 54–56 | 39, | 1 / 3 | 14% |
| 1X0G | 104 | 34–37 | 1 / 4 | 15% | |
| 2OYA | 102 | 428–431 | 1 / 4 | 15% | |
| 2OCT | 95 | 46–49 | 68, 30, 81, | 1 / 4 | 16% |
| 1BH5 | 177 | 24–36 | 2 / 13 | 24% | |
| 1J30 | 137 | 69–82 | 22, | 2 / 14 | 43.3% |
| 1H8X | 126 | 17–24 | 125, | 1 / 8 | 42% |
| 1HUL | 107 | 81–87 | 110, 112, 50, 109, 42, 40, 111, 39 | 0 / 8 | (see text) |
(a) Amino acids are listed by decreasing order; amino acids in the hinge region are underlined.
See Fig 3, Figs 5 and 6 and S2 Fig. For data sources see ref.'s [38–77].